Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts

T. Southworth (Manchester, United Kingdom), U. Kolsum (Manchester, United Kingdom), A. Higham (Manchester, United Kingdom), S. Sridhar (Gaithersburg, United States of America), T. Pham (Gaithersburg, United States of America), P. Newbold (Gaithersburg, United States of America), D. Singh (Manchester, United Kingdom)

Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Session: Advanced profiling of immune cells in chronic lung diseases
Session type: Oral Presentation
Number: 4924
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Abstract

Background: COPD patients with higher sputum or blood eosinophil counts have greater clinical response to corticosteroids and suffer lower bacterial colonisation (Kolsum et al, Respir Res 2017). Recently we have shown that these patients have higher levels of immunoglobulin (Ig) A and M proteins in their bronchoalveolar lavage (Kolsum et al, JACI 2017). 

Aims: To compare immunoglobulin and plasma cell gene expression in bronchial brushings from eosinophil high and low COPD patients.

Methods: 21 eosinophil low (blood count <150/µl) and 20 eosinophil high (>250/µl) COPD patients were recruited for bronchoscopy. Following RNA sequencing, the STAR pipeline was used to quantify bronchial brush gene expression. Differentially expressed genes and immune-related signatures were compared in eosinophil high vs low groups by ANOVA.

Results: Genes relating to IgA and IgM had greater expression in eosinophil high patients (Table 1). A plasma cell gene signature (TNFRSF17, IGKC, IGKV4-1, IGHA1) was on average expressed higher in eosinophil high patients (p=0.03)

Table 1: Comparison of IgA and IgM gene expression in eosinophil high and low patients.

gene  Fold change (high/low) p-value (high v low)
IGHA2  7.9 0.001
JCHAIN 5.3 0.005
IGHA1 5.0 0.006
IGHM 4.1 0.01

Conclusions: COPD patients with higher blood eosinophils, have more IgA, IgM and increased plasma cell gene signature in the bronchial airway. While this may play a role in reducing bacterial colonisation in these patients, further work is required to determine if this is a direct role of eosinophils or whether this is secondary to the higher, local inflammation observed in eosinophilic COPD patients.



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Southworth (Manchester, United Kingdom), U. Kolsum (Manchester, United Kingdom), A. Higham (Manchester, United Kingdom), S. Sridhar (Gaithersburg, United States of America), T. Pham (Gaithersburg, United States of America), P. Newbold (Gaithersburg, United States of America), D. Singh (Manchester, United Kingdom). Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts. 4924

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between blood eosinophil count and bronchial epithelial gene expression in COPD versus Asthma
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018



Relationship between CRTH2 mRNA expression in peripheral blood and IgE and eosinophil levels in adult patients with asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Increased activin-a expression in serum, BAL and bronchial tissue of asthmatic patients
Source: Annual Congress 2009 - Novel approaches in asthma
Year: 2009


Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 279s
Year: 2003

Comparison of cytotoxic markers expression on the surface of lymphocytes in BAL fluid and peripheral blood samples from patients with pulmonary sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 322s
Year: 2004

Comparative analysis of surface antigen expression and DNA content in circulating, tissue and bronchoalveolar lavage lymphocytes in patients with COPD after radiation exposure
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002

Increased numbers of airway wall plasma cells in smokers with chronic bronchitis: co-localization and gene expression for interleukin 4 and 5
Source: Eur Respir J 2002; 20: Suppl. 38, 378s
Year: 2002

Stability of sputum and blood eosinophil levels in COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 502s
Year: 2002

Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Human bronchial epithelial cells from patients with asthma have an altered gene expression profile
Source: ERJ Open Res, 8 (1) 00625-2021; 10.1183/23120541.00625-2021
Year: 2022



Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


Comparisons of the eosinophil cationic protein (ECP) levels and eosinophil counts in sputum of mustard lung disease (MLD) and normal subjects
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009


Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Human cytomegalovirus DNA copy number in BAL cells, white blood cells and serum from sarcoidosis patients
Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Year: 2004


Stability of blood eosinophils over time in patients with asthma
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001

Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001

The complex role of SOCS1 expression in peripheral blood mononuclears of patients with bronchial asthma
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012

Elevated blood eosinophils in bronchiectasis: A distinct phenotype?
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021